Medicines & vaccines · India

Bharat Biotech

Developed Covaxin and iNCOVACC, the first intranasal COVID-19 vaccine, as well as the Typbar-TCV typhoid conjugate and ROTAVAC vaccines.

Headquarters
Hyderabad, India · South & Southeast Asia
Value chain
Medicines & vaccines(Products)
What that means
Develops and sells therapeutics under its own name: drugs, biologics, vaccines, cell and gene therapies and radiopharmaceuticals.
Founded
1996
Ownership
Private
Website
bharatbiotech.com
Relevance
Moderate at its strongest, in Advanced Therapeutics, Vaccines & Medical Countermeasures

In 2 capabilities

Each capability the company is listed in, most relevant first: how experts in the field see its global relevance there, why it is listed and the source.

  1. Biotechnology & Health Technologies · Manufacture · listed #25 of 50

    Developed Covaxin and iNCOVACC, the first intranasal COVID-19 vaccine, as well as the Typbar-TCV typhoid conjugate and ROTAVAC vaccines.

    Relevance: Major Indian vaccine maker

    Source · en.wikipedia.org

  2. Biotechnology & Health Technologies · Manufacture · listed #33 of 50

    Major vaccine manufacturer producing Covaxin, rotavirus and typhoid conjugate vaccines with BSL-3 production capacity.

    Relevance: Major Indian vaccine manufacturer

    Source · en.wikipedia.org